-transparent.png){kind=logo}
Meglumin-Iodrinat has been synthesized as the contrasting part of Myelografin by Schering AG. and tested for lumbar Myelography in animal experiments. The excellent neural and general compatibility justified a first clinical trial. 200 patients were examined, 100 each with following upright or lying down positions. There were no local symptoms, no signs of spinal or cerebral irritation. This is seen to be the main advantage compared with drugs used so far. Intensity of contrast corresponded with that of Conray 60 and Dimer X. The most common complaints like headache and nausea were interpreted as CSF hypotension and can be clearly reduced by lying down. Also the concentration of the contrastmedium diminishes more rapidly with the patient lying down.
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
May 1978,
Rinsho hoshasen. Clinical radiography,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
January 1956,
Revue medicale de Nancy,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
March 1978,
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
May 1973,
Die Medizinische Welt,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
January 1962,
Journal belge de radiologie,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
May 1978,
Nihon geka hokan. Archiv fur japanische Chirurgie,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
November 1981,
Rinsho hoshasen. Clinical radiography,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
May 1971,
Acta radiologica: diagnosis,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
February 1955,
Fortschritte auf dem Gebiete der Rontgenstrahlen,
H Vogelsang, and
U Speck, and
P Becker, and
L Blumenbach, and
O Busse
February 1981,
The Medical journal of Australia,
